Quick answers
- What is Ferrlecit?
- Ferrlecit is a brand name of Sodium ferric gluconate complex, a prescription medicine. The FDA NDC Directory lists 2 Ferrlecit products in 1 strength and form.
- Who makes Ferrlecit?
- Sanofi Aventis US holds the FDA application for Ferrlecit (NDA020955, approved February 18, 1999).
- Is there a generic or store brand of Ferrlecit?
- Yes. The FDA NDC Directory lists 2 other products with the same active ingredients, strength and form as a Ferrlecit product, 2 of them generic. Ask your pharmacist whether one is right for you.
- Has Ferrlecit been recalled?
- No recall linked to Ferrlecit products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Ferrlecit is
Each Ferrlecit product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Sodium ferric gluconate complex · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| sodium ferric gluconate complex 12.5 mg/mL injection (intravenous) | Ferrlecit | 2 products, 1 company | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Sodium ferric gluconate complex →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA020955 | Sanofi Aventis US | February 18, 1999 | 2 |
Companies that list Ferrlecit
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Ferrlecit products.
- sanofi-aventis U.S. LLC2 products
Recalls
No recall linked to Ferrlecit products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.